Statement from Health Canada

Expanding on the statement issued on February 20, 2015, Health Canada is delivering the current update:

On February 13, 2015, Health Canada issued a “Notice of Intent to Refuse” to CEN Biotech, Inc. as a rebut to its application for a license to cultivate under the Marihuana for Medical Purposes Regulations (MMPR).

The MMPR states that Health Canada must give proper notice to applicants that it intends to reject for a license. Said applicant is then given 20 days to introduce formal written representations.

The Department has presently notified the company that the decision to deny the application is now certain.


MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Top US Marijuana Stocks To Invest In For September? 4 Of The Best Cannabis Stocks Right Now

Top Cannabis Stock For Your September 2021 Watchlist